Erasmus Uses Ingenuity for NGS Data

Jan 18, 2011

NEW YORK (GenomeWeb News) – Erasmus University Medical Center in the Netherlands is using Ingenuity Systems’ software in its next-generation sequencing-based disease and compound studies under a collaboration announced by Ingenuity today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Double-Blinded Not Preferred Review

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

This Week in PNAS

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

Grand Trees, Large Genomes

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

DNA Defense Not Convincing

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Featured White Papers

Automated Rare Disease Diagnostics

Sep

27

Featured Webinar

Large-scale, Prospective Tumor and Normal Sequence to Accelerate Biomarker Discovery and Guide Clinical Care

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep

28

Featured Webinar

Clinical Utility of Comprehensive and Fast Genomic Interpretation

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.

Main menu